Variable G protein determinants of GPCR coupling selectivity

Significance G protein-coupled receptors (GPCRs) regulate a wide variety of important cellular processes and are targeted by a large fraction of approved drugs. GPCRs signal by activating heterotrimeric G proteins and must couple to a select subset of G proteins to produce appropriate intracellular responses. It is not known how GPCRs select G proteins, but it is generally accepted that the Gα subunit C terminus is the primary G protein determinant of coupling selectivity. We systematically studied coupling of GPCRs to four families of G proteins and chimeras with C terminal regions that were exchanged between families. We uncovered rules for coupling selectivity and found that different GPCRs can recognize different features of the same G protein for selective coupling. G protein-coupled receptors (GPCRs) activate four families of heterotrimeric G proteins, and individual receptors must select a subset of G proteins to produce appropriate cellular responses. Although the precise mechanisms of coupling selectivity are uncertain, the Gα subunit C terminus is widely believed to be the primary determinant recognized by cognate receptors. Here, we directly assess coupling between 14 representative GPCRs and 16 Gα subunits, including one wild-type Gα subunit from each of the four families and 12 chimeras with exchanged C termini. We use a sensitive bioluminescence resonance energy transfer (BRET) assay that provides control over both ligand and nucleotide binding, and allows direct comparison across G protein families. We find that the Gs- and Gq-coupled receptors we studied are relatively promiscuous and always couple to some extent to Gi1 heterotrimers. In contrast, Gi-coupled receptors are more selective. Our results with Gα subunit chimeras show that the Gα C terminus is important for coupling selectivity, but no more so than the Gα subunit core. The relative importance of the Gα subunit core and C terminus is highly variable and, for some receptors, the Gα core is more important for selective coupling than the C terminus. Our results suggest general rules for GPCR-G protein coupling and demonstrate that the critical G protein determinants of selectivity vary widely, even for different receptors that couple to the same G protein.

[1]  David E. Gloriam,et al.  Receptor selectivity between the G proteins Gα12 and Gα13 is defined by a single leucine-to-isoleucine variation , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  T. Flock,et al.  Crystal structure of rhodopsin in complex with a mini-Go sheds light on the principles of G protein selectivity , 2018, Science Advances.

[3]  Naomi R. Latorraca,et al.  Structure of the mu-opioid receptor-Giprotein complex. , 2018 .

[4]  Arthur Christopoulos,et al.  Structure of the adenosine-bound human adenosine A1 receptor–Gi complex , 2018, Nature.

[5]  O. Kuybeda,et al.  Cryo-EM structure of human rhodopsin bound to an inhibitory G protein , 2018, Nature.

[6]  J. García-Nafría,et al.  Cryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go , 2018, Nature.

[7]  Naomi R. Latorraca,et al.  Structure of the μ Opioid Receptor-Gi Protein Complex , 2018, Nature.

[8]  Naomi R. Latorraca,et al.  Gi- and Gs-coupled GPCRs show different modes of G-protein binding , 2018, Proceedings of the National Academy of Sciences.

[9]  Alexander S. Hauser,et al.  GPCRdb in 2018: adding GPCR structure models and ligands , 2017, Nucleic Acids Res..

[10]  J. Wess,et al.  Lack of beta-arrestin signaling in the absence of active G proteins , 2018, Nature Communications.

[11]  Arthur Christopoulos,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors , 2017, British journal of pharmacology.

[12]  M. Madan Babu,et al.  Selectivity determinants of GPCR–G-protein binding , 2017, Nature.

[13]  J. Aoki,et al.  Purinergic Receptor Transactivation by the β2-Adrenergic Receptor Increases Intracellular Ca2+ in Nonexcitable Cells , 2017, Molecular Pharmacology.

[14]  G. Milligan,et al.  The emerging pharmacology and function of GPR35 in the nervous system , 2017, Neuropharmacology.

[15]  Donna Webb,et al.  Coupling optogenetic stimulation with NanoLuc-based luminescence (BRET) Ca++ sensing , 2016, Nature Communications.

[16]  C. Tate,et al.  Engineering a minimal G protein to facilitate crystallisation of G protein-coupled receptors in their active conformation , 2016, Protein engineering, design & selection : PEDS.

[17]  N. Vaidehi,et al.  Structural Elements in the Gαs and Gαq C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling* , 2016, The Journal of Biological Chemistry.

[18]  A. J. Venkatakrishnan,et al.  Universal allosteric mechanism for Gα activation by GPCRs , 2015, Nature.

[19]  H. Horiuchi Seven-transmembrane receptors , 2015 .

[20]  Helmut Grubmüller,et al.  Position of transmembrane helix 6 determines receptor G protein coupling specificity. , 2014, Journal of the American Chemical Society.

[21]  T. Lan,et al.  Sensitive and High Resolution Localization and Tracking of Membrane Proteins in Live Cells with BRET , 2012, Traffic.

[22]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[23]  Xavier Deupi,et al.  The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex , 2009, Proceedings of the National Academy of Sciences.

[24]  N. Lambert,et al.  The c-terminus of GRK3 indicates rapid dissociation of G protein heterotrimers. , 2009, Cellular signalling.

[25]  Michel Bouvier,et al.  Real-time monitoring of receptor and G-protein interactions in living cells , 2005, Nature Methods.

[26]  R. Lefkowitz,et al.  Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.

[27]  B. Kobilka,et al.  Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Bockaert,et al.  A Novel Site on the Gα-protein That Recognizes Heptahelical Receptors* , 2001, The Journal of Biological Chemistry.

[29]  J. Bockaert,et al.  A novel site on the Galpha -protein that recognizes heptahelical receptors. , 2001, The Journal of biological chemistry.

[30]  C. Berlot,et al.  A surface-exposed region of G(salpha) in which substitutions decrease receptor-mediated activation and increase receptor affinity. , 2000, Molecular pharmacology.

[31]  J. Wess,et al.  Molecular basis of receptor/G-protein-coupling selectivity. , 1998, Pharmacology & therapeutics.

[32]  M. Grossmann,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[33]  J. Wess,et al.  The N-terminal Extension of Gαq Is Critical for Constraining the Selectivity of Receptor Coupling* , 1997, The Journal of Biological Chemistry.

[34]  J. Wess,et al.  Molecular basis of receptor/G protein coupling selectivity studied by coexpression of wild type and mutant m2 muscarinic receptors with mutant G alpha(q) subunits. , 1997, Biochemistry.

[35]  B. Conklin,et al.  Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation. , 1996, Molecular pharmacology.

[36]  J. Shine,et al.  Protein-coupled Receptors , 1996 .

[37]  J. Wess,et al.  Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Simon,et al.  Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor. , 1995, Molecular pharmacology.

[39]  E. Lakatta,et al.  Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. , 1995, Molecular pharmacology.

[40]  B. Conklin,et al.  Substitution of three amino acids switches receptor specificity of Gqα to that of Giα , 1993, Nature.

[41]  R. Seifert,et al.  Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue. , 1992, Molecular pharmacology.

[42]  Melvin I. Simon,et al.  Diversity of G proteins in signal transduction , 1991, Science.

[43]  W. Simonds,et al.  Gi2 mediates alpha 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: in situ identification with G alpha C-terminal antibodies. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Hamm,et al.  Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit. , 1988, Science.

[45]  W. Heideman,et al.  Identification of receptor contact site involved in receptor–G protein coupling , 1987, Nature.

[46]  J. Moss,et al.  Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. , 1985, The Journal of biological chemistry.

[47]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[48]  M. Maguire,et al.  An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor. , 1976, Molecular pharmacology.